
Ahead of World Heart Day, Amgen has released a study demonstrating that patient education is still necessary to combat cardiovascular disease.

Ahead of World Heart Day, Amgen has released a study demonstrating that patient education is still necessary to combat cardiovascular disease.

Daratumumab was approved based on results from part one of the Phase III CASSIOPEIA study.

Patients with metastatic colorectal cancer harboring certain non-V600 BRAF mutations may benefit from anti-EGFR treatment.

Value assessment frameworks are expected to play a more pivotal role in decisions that affect future patient choice and access.

The vitamin D and omega-3 clinical trial (VITAL) is the largest, most recent study to test this subject matter, with nearly 26,000 United States men and women participating in the trial.










Study indicated that patients who received radiation 30 days or fewer before their CAR T-cell infusion did not experience serious cytokine release syndrome or neurotoxicity.

Mammography found more effective at detecting breast cancer in men with high risk than for women with an average risk and in detecting the disease before it metastasizes.


Top news of the day across the health care landscape.

The FDA approved Jynneos (Bavarian Nordic) as the first live, nonreplicating vaccine to prevent smallpox and monkeypox.

On September 25, 2019, millions of pharmacists worldwide will celebrate World Pharmacists Day, this year themed “safe and effective medicines for all.”

Top news of the day across the health care landscape.

Study participants who consumed approximately 500 mg of total flavonoids each day had the lowest risk of a cancer or heart disease-related death.

The postponement of USP chapters , , and was applauded by the International Academy of Compounding Pharmacists.

Study shows that higher levels of PTSD symptoms can be associated with increased risks of ovarian cancer even decades after women experience a traumatic event.

The report is the result of collaboration among experts across the agency and incorporates important input from patients, researchers, and advocates.

In a Pharmacy Times Continuing Education Supplement, Elena E. Perez, MD, PhD, examined the evolution of immunoglobulin [Ig] in its treatment use, including patient populations and potential adverse events.

Patients with diabetes demonstrated a higher likelihood of developing non-Hodgkin lymphoma than those without diabetes, especially among men.

Top news of the day across the health care landscape.

What caused the abdominal pain that lead to the bowel resection?